Quarterly report pursuant to Section 13 or 15(d)

INVESTMENT (Details Narrative)

v3.23.1
INVESTMENT (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
I Li A D Biotechnologies L L C [Member]    
Schedule of Equity Method Investments [Line Items]    
Aggregrate investment $ 7,000,000  
Book value of the investment $ 4,254,000  
Iliad [Member] | Class C Units [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage not fully diluted 6.80%  
Iliad [Member]    
Schedule of Equity Method Investments [Line Items]    
Aggregrate investment $ 7,000,000  
Equity investment net loss $ 674,000 $ 433,000
Iliad [Member] | Class C Units [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage fully diluted 6.10%